Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Von der Leyen: Paris meeting sends signal of unity for Ukraine - 2Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- 3How 2025 became the year of comet: The rise of interstellar 3I/ATLAS, an icy Lemmon and a cosmic SWAN
- 4High velocity Internet services for Metropolitan Regions
- 5Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video)
- Savvy Cleaning: The 6 Robot Vacuums of 2024
- Tatiana Schlossberg, a granddaughter of JFK, is dead at 35 after cancer diagnosis
- When fake data is a good thing – how synthetic data trains AI to solve real problems
- Motivational Travel Objections for History Buffs
- How much should a kid's birthday party cost? One mom spent $190 for pizza and ice cream at a park. Another paid $2K for a playspace and goodie bags.
- Jasmine Crockett in, Colin Allred out: A major shakeup for Democrats in their quest to finally win a Senate seat in Texas
- What we know about the Brown University shooting suspect who was found dead, and how police linked him to the MIT killing
- U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
- At least 490 protesters killed in Iran, activists say
